Comparison of Anemia Outcomes between SGLT2 Inhibitors and GLP-1 Receptor Agonists in Diabetic Patients with Chronic Kidney Disease: Multi-institutional Cohort Study with Target Trial Emulation in Taiwan

被引：0
|
作者：
Shao, Shih-Chieh [1 ]
Hu, Jia-Chian [2 ]
Tsai, Daniel Hsiang-Te [3 ]
Chuang, Albert Tzu-Ming [2 ]
Liu, Kuan-Hung [4 ]
Lai, Edward Chia-Cheng [5 ]
机构：
[1] Keelung Chang Gung Mem Hosp, Keelung, Taiwan
[2] Natl Cheng Kung Univ, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Sch Pharm, Coll Med, Tainan, Taiwan
[4] Natl Cheng Kung Univ Hosp, Tainan, Taiwan
[5] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Coll Med, Tainan, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
1193
引用
收藏
页码：537 / 537
页数：1
相关论文
共 50 条
  • [1] Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease
    Tang, Mengyao
    Morieri, Mario Luca
    Kalim, Sahir
    Doria, Alessandro
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2025,
  • [2] Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease
    Li, Jiahua
    Albajrami, Oltjon
    Zhuo, Min
    Hawley, Chelsea E.
    Paik, Julie M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (11): : 1678 - 1688
  • [3] Inflammation and Oxidative Stress in Diabetic Kidney Disease: The Targets for SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Winiarska, Agata
    Knysak, Monika
    Nabrdalik, Katarzyna
    Gumprecht, Janusz
    Stompor, Tomasz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [4] Kidney and Cardiovascular Outcomes With SGLT2 Inhibitors and/or GLP-1 Receptor Agonists in Type 2 Diabetes
    Neuen, Brendon L.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (08) : 709 - 711
  • [5] Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Scott Cohen
    Hillel Sternlicht
    George L. Bakris
    Current Diabetes Reports, 2022, 22 : 213 - 218
  • [6] Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists
    Cohen, Scott
    Sternlicht, Hillel
    Bakris, George L.
    CURRENT DIABETES REPORTS, 2022, 22 (05) : 213 - 218
  • [7] Comparative Effectiveness of SGLT2 Inhibitors, GLP-1 Receptor Agonists, DPP-4 Inhibitors, and Sulfonylureas on Risk of Kidney Outcomes: Emulation of a Target Trial Using Health Care Databases
    Xie, Yan
    Bowe, Benjamin
    Gibson, Andrew K.
    McGill, Janet B.
    Maddukuri, Geetha
    Yan, Yan
    Al-Aly, Ziyad
    DIABETES CARE, 2020, 43 (11) : 2859 - 2869
  • [8] A New Hope on the Horizon for Kidney and Cardiovascular Protection with SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Mineralocorticoid Receptor Antagonists in Type 2 Diabetic and Chronic Kidney Disease Patients
    Spasovski, Goce
    Rroji, Merita
    Hristov, Goce
    Bushljetikj, Oliver
    Spahia, Nereida
    Bushletikj, Irena Rambabova
    METABOLIC SYNDROME AND RELATED DISORDERS, 2024, 22 (03) : 170 - 178
  • [9] Comparative effectiveness of GLP-1 receptor agonists versus SGLT2 inhibitors in patients with type 2 diabetes and moderate chronic kidney disease
    Rossing, P.
    Fioretto, P.
    Clark, A.
    Jensen, A. B.
    Nazal, N. Belmar
    Tuttle, K. R.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S356 - S357
  • [10] Effects of SGLT2 inhibitors on anemia in patients with diabetes and chronic kidney disease: A population-based cohort study using target trial emulation framework
    Hu, Jia-Chian
    Shao, Shih-Chieh
    Tsai, Daniel Hsiang-Te
    Chuang, Albert Tzu-Ming
    Liu, Kuan-Hung
    Lai, Edward Chia-Cheng
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 65 - 65
12345